Download presentation
Presentation is loading. Please wait.
Published byJemima Glenn Modified over 6 years ago
1
Monitoring Tracings US (bpm) LV FHR (bpm) Pulse ox LV MHR (bpm) VS.
Toco (mmHg) LV FHR (bpm) LV MHR (bpm) LV UA (mmHg) VS.
2
Reliable and accurate monitoring (regardless of BMI)ˡ
Maternal Heart Rate Fetal Heart Rate Uterine Contractions 1. FDA Clinical Trial
3
Normal weight patient (BMI 24.2)
US (bpm) Pulse ox Toco (mmHg) LV FHR (bpm) LV MHR (bpm) LV UA (mmHg)
4
Overweight patient (BMI 29.3)
US (bpm) Pulse ox Toco (mmHg) LV FHR (bpm) LV MHR (bpm) LV UA (mmHg)
5
Moderately obese patient (BMI 31.1)
US (bpm) Pulse ox Toco (mmHg) LV FHR (bpm) LV MHR (bpm) LV UA (mmHg)
6
Severely obese patient (BMI 37.8)
US (bpm) Pulse ox Toco (mmHg) LV FHR (bpm) LV MHR (bpm) LV UA (mmHg)
7
Morbidly obese patient (BMI 53.7)
US (bpm) Pulse ox Toco (mmHg) LV FHR (bpm) LV MHR (bpm) LV UA (mmHg)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.